Potential first-in-class therapeutic for urea cycle disorders enters trial
Drug Discovery World
MARCH 26, 2024
Mutations in genes encoding urea cycle enzymes result in insufficient levels of these important proteins. CMP-CPS-001 is an antisense oligonucleotide (ASO) designed to amplify CPS1 mRNA by harnessing fundamental cellular gene expression control mechanisms.
Let's personalize your content